{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:14:30Z","timestamp":1791688470221,"version":"4.3.4"},"reference-count":132,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cld.2024.12.008","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:39:50Z","timestamp":1738759190000},"page":"313-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrent and De Novo Liver Disease After Liver Transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Sally","family":"Condon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation","volume":"10","author":"DiMartini","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib7","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.cld.2024.12.008_bib8","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.23936","article-title":"Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis","volume":"20","author":"Vallin","year":"2014","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib10","article-title":"Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis","volume":"5","author":"Villeret","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2013.04.004","article-title":"Monogenic diseases that can be cured by liver transplantation","volume":"59","author":"Fagiuoli","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2S1","key":"10.1016\/j.cld.2024.12.008_bib12","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.ajt.2024.01.014","article-title":"OPTN\/SRTR 2022 annual data report: liver","volume":"24","author":"Kwong","year":"2024","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jhep.2018.07.020","article-title":"A\u00a0changing landscape of liver transplantation: king HCV is dethroned, ALD and NAFLD take over","volume":"69","author":"Terrault","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib15","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/hep.32067","article-title":"Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the USA","volume":"74","author":"Cholankeril","year":"2021","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.cld.2024.12.008_bib16","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.12.008_bib17","unstructured":"United Network for Organ Sharing (UNOS) Website. OPTN Data and Reports. Available at: https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/build-advanced\/. (Accessed July 2024)."},{"issue":"8","key":"10.1016\/j.cld.2024.12.008_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","author":"Dumortier","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2024.12.008_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/lt.23762","article-title":"Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis","volume":"19","author":"Rice","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cgh.2020.11.024","article-title":"Patterns of alcohol use after early liver transplantation for alcoholic hepatitis","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lt.25647","article-title":"Natural history of recurrent alcohol-related cirrhosis after liver transplantation: fast and furious","volume":"26","author":"Erard-Poinsot","year":"2020","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib22","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.cld.2024.12.008_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/lt.26492","article-title":"CAQ Corner: disease recurrence after liver transplantation","volume":"29","author":"Goel","year":"2023","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1053\/j.gastro.2021.08.004","article-title":"Results of early transplantation for alcohol-related cirrhosis: integrated addiction treatment with low rate of relapse","volume":"161","author":"Carrique","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12876-019-1050-9","article-title":"Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis","volume":"19","author":"Chuncharunee","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2024.12.008_bib26","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10620-019-05937-4","article-title":"Prior relapse, ongoing alcohol consumption, and failure to engage in treatment predict alcohol relapse after liver transplantation","volume":"65","author":"Deutsch-Link","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/lt.21278","article-title":"Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs","volume":"14","author":"Dew","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/lt.23797","article-title":"Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan","volume":"20","author":"Egawa","year":"2014","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0012.2011.01489.x","article-title":"Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors","volume":"26","author":"Lamba","year":"2012","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.30478","article-title":"Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7182\/pit2013604","article-title":"The Alcohol Relapse Risk Assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant","volume":"23","author":"Rodrigue","year":"2013","journal-title":"Prog Transplant"},{"issue":"11","key":"10.1016\/j.cld.2024.12.008_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamasurg.2021.3748","article-title":"Evaluation of early vs standard liver transplant for alcohol-associated liver disease","volume":"156","author":"Herrick-Reynolds","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1530-0277.1992.tb01908.x","article-title":"The short-term psychological health of alcoholic and non-alcoholic liver transplant recipients","volume":"16","author":"Beresford","year":"1992","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/PSY.0000000000000241","article-title":"The stanford integrated psychosocial assessment for transplantation: a prospective study of medical and psychosocial outcomes","volume":"77","author":"Maldonado","year":"2015","journal-title":"Psychosom Med"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.15288\/jsa.1993.54.645","article-title":"Descriptive and predictive validity of a high-risk alcoholism relapse model","volume":"54","author":"Yates","year":"1993","journal-title":"J\u00a0Stud Alcohol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/lt.25681","article-title":"Meeting report: the Dallas Consensus conference on liver transplantation for alcohol associated hepatitis","volume":"26","author":"Asrani","year":"2020","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365520410009591","article-title":"Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism","volume":"40","author":"Bjornsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.14521","article-title":"Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients","volume":"47","author":"Losurdo","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/LVT.0000000000000060","article-title":"Hepatic steatosis after liver transplantation: a systematic review and meta-analysis","volume":"29","author":"Silva","year":"2023","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2024.12.008_bib45","article-title":"Genetic and life style risk factors for recurrent non-alcoholic fatty liver disease following liver transplantation","volume":"8","author":"Iacob","year":"2021","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lt.25657","article-title":"Nonalcoholic steatohepatitis after liver transplantation","volume":"26","author":"Cotter","year":"2020","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jceh.2013.04.005","article-title":"Current status of immunosuppression in liver transplantation","volume":"3","author":"Choudhary","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13000-022-01247-y","article-title":"Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting","volume":"17","author":"Balitzer","year":"2022","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/lt.24393","article-title":"Prevalence and risk factors of steatosis after liver transplantation and patient outcomes","volume":"22","author":"Hejlova","year":"2016","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","article-title":"Liver transplantation for nonalcoholic steatohepatitis: the new epidemic","volume":"256","author":"Agopian","year":"2012","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.cld.2024.12.008_bib51","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","article-title":"Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis","volume":"101","author":"Bhati","year":"2017","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clinre.2012.11.003","article-title":"Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation","volume":"37","author":"Barrault","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib53","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17474124.2022.2137488","article-title":"Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival","volume":"16","author":"Eshraghian","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.transproceed.2020.02.160","article-title":"The utility of assessing liver allograft fibrosis and steatosis post-liver transplantation using transient elastography with controlled attenuation parameter","volume":"53","author":"Chayanupatkul","year":"2021","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.cld.2024.12.008_bib55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/lt.24137","article-title":"Cardiovascular disease after liver transplantation: when, what, and who is at risk","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2024.12.008_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2023.1223169","article-title":"Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis","volume":"2","author":"Atthota","year":"2023","journal-title":"Front Transplant"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/LVT.0000000000000233","article-title":"Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients","volume":"30","author":"Richardson","year":"2024","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib58","first-page":"137","article-title":"Single-Center north American experience of liver transplantation in autoimmune hepatitis: infrequent indication but good outcomes for patients","volume":"4","author":"de Quadros Onofrio","year":"2021","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib59","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cld.2011.08.008","article-title":"Recurrent and de novo autoimmune liver diseases","volume":"15","author":"Mendes","year":"2011","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib60","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and de novo autoimmune hepatitis","volume":"25","author":"Stirnimann","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2024.12.008_bib61","article-title":"Recurrence of autoimmune liver diseases after liver transplantation: review and expert opinion statement","author":"Montano-Loza","year":"2024","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2024.12.008_bib63","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First-degree living-related donor liver transplantation in autoimmune liver diseases","volume":"16","author":"Aravinthan","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"Liver biopsy interpretation for causes of late liver allograft dysfunction","volume":"44","author":"Banff","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib66","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib67","first-page":"331","article-title":"Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation","volume":"68","author":"Duclos-Vallee","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome","volume":"7","author":"Hubscher","year":"2001","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0676.1997.tb01038.x","article-title":"Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"17","author":"Sempoux","year":"1997","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib72","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/LVT.0000000000000278","article-title":"Autoimmune hepatitis recurrence after liver transplantation: \u201cLes jeux sont faits\u201d","volume":"30","author":"Chouik","year":"2024","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib75","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transplant"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2024.12.008_bib77","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib78","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib81","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib82","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"issue":"9100","key":"10.1016\/j.cld.2024.12.008_bib83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2005.00470.x","article-title":"Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation","volume":"10","author":"Gibelli","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib85","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2024.12.008_bib86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2018.10.023","article-title":"De novo autoimmune hepatitis -is this different in adults compared to children?","volume":"95","author":"Kerkar","year":"2018","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","article-title":"De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis","volume":"22","author":"Yoshizawa","year":"2008","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib89","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.transproceed.2010.08.062","article-title":"De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report","volume":"42","author":"Zhang","year":"2010","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib90","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib91","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib92","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0168-8278(95)80033-6","article-title":"Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis","volume":"23","author":"Dubel","year":"1995","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib93","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cld.2022.06.014","article-title":"Liver transplantation for primary biliary cholangitis","volume":"26","author":"Martin","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib94","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib95","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.cld.2024.12.008_bib96","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib97","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib99","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib101","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib102","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib103","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2024.12.008_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.05.010","article-title":"Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation","author":"Montano-Loza","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib107","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"11 Suppl 2","key":"10.1016\/j.cld.2024.12.008_bib108","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/lt.20947","article-title":"Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection","volume":"12","author":"Demetris","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2024.12.008_bib111","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib112","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2024.12.008_bib113","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib114","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9349","key":"10.1016\/j.cld.2024.12.008_bib115","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cld.2024.12.008_bib116","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2024.12.008_bib117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib118","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2024.12.008_bib119","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib121","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"Supplement_1","key":"10.1016\/j.cld.2024.12.008_bib122","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/ecco-jcc\/jjac190.0010","article-title":"OP10 Proctocolectomy with permanent ileostomy is associated with better transplant-free survival in patients with primary sclerosing cholangitis: a retrospective cohort study","volume":"17","author":"Mol","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib123","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib124","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/TP.0000000000000447","article-title":"Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution","volume":"99","author":"Sundaram","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2024.12.008_bib125","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2017.06.027","article-title":"Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis","volume":"67","author":"Trivedi","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"15","key":"10.1016\/j.cld.2024.12.008_bib126","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation - a randomized trial","volume":"384","author":"van Rijn","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.12.008_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/wjs.12281","article-title":"Untangling biliary reconstruction in liver transplants for primary sclerosing cholangitis","author":"Alwis","year":"2024","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.cld.2024.12.008_bib128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of Duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana","year":"2015","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.cld.2024.12.008_bib129","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00268-001-0162-9","article-title":"Changes in bacterial concentration in the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction: implication in the pathogenesis of postoperative cholangitis","volume":"25","author":"Chuang","year":"2001","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.cld.2024.12.008_bib130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/s-2007-966841","article-title":"Double-balloon enteroscopy for endoscopic retrograde cholangiography in patients with a Roux-en-Y anastomosis","volume":"39","author":"Aabakken","year":"2007","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.cld.2024.12.008_bib131","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1572-0241.2004.04050.x","article-title":"Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC","volume":"99","author":"Maheshwari","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2024.12.008_bib132","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transpl"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:24:59Z","timestamp":1750375499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1089326124001156"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.12.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent and De Novo Liver Disease After Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}